Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

We performed a randomized, controlled trial of intravenous immune globulin (respiratory syncytial virus [RSV] neutralizing [Nt] antibody titer of 1:950 in 5% solution) to evaluate protection against RSV-induced disease over two respiratory virus seasons. Forty-nine children (mean age at enrollment,...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Meissner, H C, Fulton, D R, Groothuis, J R, Geggel, R L, Marx, G R, Hemming, V G, Hougen, T, Snydman, D R
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1993
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188036/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8215279/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.8.1655
Oznake:	Označite Brez oznak, prvi označite!